GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 2,279 | 4,056 | 3,092 | 234,660 | 5,157 |
| Operating Income | -2,279 | -4,056 | -3,092 | -234,660 | -5,157 |
| Interest Expense | 479 | 454 | 1,139 | 1,123 | 3,924 |
| Other Income | -31 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,789 | -4,510 | -4,231 | -235,783 | -9,081 |
| Net Income Continuous | -2,789 | -4,510 | -4,231 | -235,783 | -9,081 |
| Net Income | $-2,789 | $-4,510 | $-4,231 | $-235,783 | $-9,081 |
| EPS Basic Total Ops | -25.54 | -45.96 | -40.86 | -2,400.36 | -91.93 |
| EPS Basic Continuous Ops | -27.44 | -45.08 | -38.47 | -2,400.92 | -92.54 |
| EPS Diluted Total Ops | -25.54 | -45.96 | -40.86 | -2,400.36 | -91.93 |
| EPS Diluted Continuous Ops | -27.44 | -45.08 | -38.47 | -2,400.92 | -92.54 |
| EBITDA(a) | $-2,102 | $-3,892 | $-2,243 | $-233,027 | $-966 |